Docking simulation study and kinase selectivity of f152A1 and its analogs

Journal of Chemical Information and Modeling

Volumn 52, Issue 8, 2012, Pages 2059-2068

  Ikemori Kawada, Megumi ^a   Inoue, Atsushi ^a   Goto, Masaki ^a   Wang, Yuan John ^b   Kawakami, Yoshiyuki ^a  

^a EISAI CO LTD   (Japan)

^b EISAI INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADDITION REACTIONS; BINDING SITES; CHEMICAL ANALYSIS; CONFORMATIONS; MODEL STRUCTURES; MOLECULAR ORBITALS;

CHEMICAL BONDINGS; CONFORMATIONAL ANALYSIS; DOCKING SIMULATIONS; INHIBITION PROFILE; MICHAEL ADDITION REACTIONS; MOLECULAR DOCKING; MOLECULAR ORBITAL STUDIES; POTENT INHIBITOR;

ENZYMES;

LACTONE; LL Z1640 2; LL Z1640-2; PROTEIN KINASE; PROTEIN KINASE INHIBITOR;

AMINO ACID SEQUENCE; ARTICLE; CHEMISTRY; ENZYME SPECIFICITY; HUMAN; METABOLISM; MOLECULAR DOCKING; MOLECULAR GENETICS; PROTEIN CONFORMATION;

AMINO ACID SEQUENCE; HUMANS; LACTONES; MOLECULAR DOCKING SIMULATION; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; SUBSTRATE SPECIFICITY;

EID: 84865471424     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci300135g     Document Type: Article

References (24)

1. Goto, M.; Chow, J.; Muramoto, K.; Chiba, K.; Yamamoto, S.; Fujita, M.; Obaishi, H.; Tai, K.; Mizui, Y.; Tanaka, I.; Young, D.; Yang, H.; Wang, Y. J.; Shirota, H.; Gusovsky, F. E6201 [(3S,4R,5Z,8S,9S,11E)-14-(Ethylamino)-8, 9,16-trihydroxy-3, 4-dimethyl-3,4,9,10-tetrahydro-1H-2-benzoxacyclotetradecine- 1,7(8H)-dione], a Novel Kinase Inhibitor of Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase (MEK)-1 and MEK Kinase-1: In Vitro Characterization of Its Anti-Inflammatory and Anti hyper proliferative Activities J. Pharmacol. Exp. Ther. 2009, 331, 485-495
2. Du, H.; Matsushima, T.; Spyvee, M.; Goto, M.; Shirota, H.; Gusovsky, F.; Chiba, K.; Kotake, M.; Yoneda, N.; Eguchi, Y.; DiPietro, L.; Harmange, J. C.; Gilbert, S.; Li, X. Y.; Davis, H.; Jiang, Y.; Zhang, Z.; Pelletier, R.; Wong, N.; Sakurai, H.; Yang, H.; Ito-Igarashi, H.; Kimura, A.; Kuboi, Y.; Mizui, Y.; Tanaka, I.; Ikemori-Kawada, M.; Kawakami, Y.; Inoue, A.; Kawai, T.; Kishi, Y.; Wang, Y. Discovery of a potent, metabolically stabilized resorcylic lactone as an anti-inflammatory lead Bioorg. Med. Chem. Lett. 2009, 19, 6196-6199
3. Shen, Y.; Du, H.; Kotake, M.; Matsushima, T.; Goto, M.; Shirota, H.; Gusovsky, F.; Li, X.; Jiang, Y.; Schiller, S.; Spyvee, M.; Davis, H.; Zhang, Z.; Pelletier, R.; Ikemori-Kawada, M.; Kawakami, Y.; Inoue, A.; Wang, Y. Discovery of an in vitro and in vivo potent resorcylic lactone analog of LL-Z1640-2 as anti-inflammatory lead, II. Bioorg. Med. Chem. Lett. 2010, 20, 3047-3049
4. Shen, Y.; Boivin, R.; Yoneda, N.; Du, H.; Schiller, S.; Matsushima, T.; Goto, M.; Shirota, H.; Gusovsky, F.; Lemelin, C.; Jiang, Y.; Zhang, Z.; Pelletier, R.; Ikemori-Kawada, M.; Kawakami, Y.; Inoue, A.; Schnaderbeck, M.; Wang, Y. Discovery of anti-inflammatory clinical candidate E6201, inspired from resorcylic lactone LL-Z1640-2, III. Bioorg. Med. Chem. Lett. 2010, 20, 3155-3157
5. Muramoto, K.; Goto, M.; Inoue, Y.; Ishii, N.; Chiba, K.; Kuboi, Y.; Omae, T.; Wang, Y. J.; Gusovsky, F.; Shirota, H. E6201, a novel kinase inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-1 and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase-1: in vivo effects on cutaneous inflammatory responses by topical administration J. Pharmacol. Exp. Ther. 2010, 335, 23-31
6. Ikemori-Kawada, M; Kawai, T.; Goto, M.; Wang, Y. J.; Kawakami, Y. Conformational analyses and MO studies of f152A1 and its analogues as potent protein kinase inhibitors J. Chem. Inf. Model. 2009, 49, 2650-2659
7. Ohori, M.; Kinoshita, T.; Yoshimura, S.; Warizaya, M.; Nakajima, H.; Miyake, H. Role of a cystein residue in the active site of ERK and the MAPKK family Biochem. Biophys. Res. Commun. 2007, 353, 633-637 (Pubitemid 46048715)
8. Agatsuma, T.; Takahashi, A.; Kabuto, C.; Nozoe, S. Revised structure of hypothemycin Chem. Pharm. Bull. 1993, 41, 373-375
9. Schirmer, A.; Kennedy, J.; Murli, S.; Reid, R.; Santi, D. V. Targeted covalent inactivation of protein kinases by resorcylic acid lactone polyketides Proc. Natl. Acad. Sci. USA. 2006, 103, 4234-4239
10. Nair, M. S. R.; Carey, S. T.; James, J. C. Metabolites of pyrenomycetes. XIV1: Structure and partial stereochemistry of the antibiotic macrolides hypothemycin and dihydrohypothemycin Tetrahedron 1981, 37, 2445-2449
11. Rastelli, G.; Rosenfeld, R.; Reid, R.; Santi, D. V. Molecular modeling and crystal structure of ERK2-hypothemycin complexes J. Struct. Biol. 2008, 164, 18-23
12. Kawai, T.; Ichinose, T.; Endo, Y.; Shudo, K.; Itai, A. Active conformation of a tumor promoter, teleocidin. A molecular dynamics study J. Med. Chem. 1992, 35, 2248-2253
13. Traxlera, P.; Fureta, P. Strategies toward the design of novel and selective protein tyrosine kinase inhibitors Pharmacol. Ther. 1999, 82, 195-206
14. Weiner, S. J.; Kollman, P. A.; Case, D.; Singh, U. C.; Ghio, C.; Alagona, G.; Profeta, S.; Weiner, P. K. A new force field for molecular mechanical simulation of nucleic acids and proteins J. Am. Chem. Soc. 1984, 106, 765-784 (Pubitemid 14548426)
15. Halgren, T. A. Merck Molecular Force Field. V. Extension of MMFF94 using experimental data, additional computational data and empirical rules J. Comput. Chem. 1996, 17, 616-641 (Pubitemid 126567071)
16. Stewart, J. J. P. MOPAC A Semiempirical Molecular Orbital Program J. Computer-Aided Mol. Des. 1990, 4, 1-105
17. Zuccotto, F.; Ardini, E.; Casale, E.; Angiolini, A. Through the "Gatekeeper Door": Exploiting the Active Kinase Conformation J. Med. Chem. 2010, 53, 2681-2694
18. Discover Studio, ver.2.1; Accelrys Software Inc., SanDiego, CA.
19. Jacobson, M. P.; Friesner, R. A.; Xiang., Z.; Honig, B. On the Role of Crystal Packing Forces in Determining Protein Sidechain Conformations J. Mol. Biol. 2002, 320, 597-608 (Pubitemid 34753983)
20. Jacobson, M. P.; Pincus, D. L.; Rapp, C. S.; Day, T. J. F.; Honig, B.; Shaw, D. E.; Friesner, R. A. A Hierarchical Approach to All-Atom Protein Loop Prediction Proteins 2004, 55, 351-367 (Pubitemid 38437493)
21. Sherman, W.; Day, T.; Jacobson, M. P.; Friesner, R. A.; Farid, R. Novel Procedure for Modeling Ligand/Receptor Induced Fit Effects J. Med. Chem. 2006, 49, 534-554
22. Friesner, R. A.; Banks, J. L.; Murphy, R. B.; Halgren, T. A.; Klicic, J. J.; Mainz, D. T.; Repasky, M. P.; Knoll, E. H.; Shaw, D. E.; Shelley, M.; Perry, J. K.; Francis, P.; Shenkin, P. S. Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy J. Med. Chem. 2004, 47, 1739-1749 (Pubitemid 38380917)
23. Cho, A. E.; Guallar, V.; Berne, B.; Friesner, R. A. Importance of Accurate Charges in Molecular Docking: Quantum Mechanical/Molecular Mechanical (QM/MM) Approach J. Comput. Chem. 2005, 26, 915-931 (Pubitemid 40860395)
24. Maestro, ver.9.0; Schrödinger, LLC, Portland, OR.